Apptio Unveils Conversational Insights and New Suite of AI-Powered Capabilities to Translate Complex Technology Spend into Measurable Business Outcomes

• Apptio is launching a preview of new Conversational Insights solution that allows any stakeholder to ask plain-language questions and get data-backed insights into their technology spend and value across the entire Apptio product suite
• Apptio customers will get several updates across the solution suite, including IBM Apptio Data Center Total Cost of Ownership, Cloudability Intelligent Forecasting, and Cloudability Advanced Containers, enabling end-to-end visibility and control across the entire hybrid IT estate
• The updates further enhance the Financial Intelligence Layer for technology to address blind spots and connect cost to value, empowering teams to assess whether every technology investment delivers a measurable business outcome

BELLEVUE, Wash., June 16, 2026 /PRNewswire/ -- Today, Apptio, an IBM Company (NYSE: IBM), announced significant updates to its solution suite—including the launch of its Conversational Insights, currently in preview, and new capabilities for hybrid IT cost management and cloud optimization—designed to turn technology investment into measurable business outcomes and establish best practices for the financial governance for AI in a time of record infrastructure investments. The new capabilities are designed to specifically strengthen Apptio's Financial Intelligence Layer that connects cost, consumption, value, and action across all spending and operational data within the enterprise. 

As businesses rush to capitalize on AI, "global IT spending is poised to reach $6.15 trillion in 2026, up 10.8% from 2025", according to the latest forecast by Gartner®^[1] to meet these demands. This rapid investment in AI within already complex hybrid IT environments is creating significant financial blind spots, making it nearly impossible to connect AI-driven costs to business value.

At the same time, executives are being asked to justify the value of massive AI expenditures they cannot fully see or track. Apptio's 2026 Technology Investment Management Report found that 90% of leaders surveyed say ROI uncertainty impacts their tech investment decisions. To overcome this, organizations must unify financial and operational data across their technology estate, moving from siloed tools to a single source of truth for all technology investments.

"Technology is no longer a cost center; it is the engine of modern business," said Bill Lobig, Vice President Apptio. "This reality demands a shift from reactive reporting to proactive, real-time monitoring of spend. With the introduction of our new AI-infused capabilities, we are providing the automated, real-time insights leaders need to manage the complexity of hybrid IT to help ensure their technology investments become their greatest competitive advantage."

Conversational Insights: Powering the Financial Intelligence Layer

To address this challenge, Apptio is launching Conversational Insights, an enterprise-grade conversational interface with AI embedded across the company's entire solutions portfolio. Built with Technology Business Management (TBM) principles in mind, the new interface is designed to connect financial, operational and business data across systems in order to help leaders better manage IT costs, optimize cloud spending and align strategic portfolios.

This natural language AI interface allows stakeholders to ask plain-language questions about project status, resource allocation, and financial performance and get immediate, data-backed answers. By providing easy-to-understand insights into cloud spend, Conversational Insights empowers users –– across technical abilities––with a FinOps approach to making informed decisions about IT investments, to ultimately meet financial targets.

Unlike generic, bolt-on AI tools, Apptio's Conversational Insights is natively embedded within the Apptio platform and across the solutions portfolio. This purpose-built architecture delivers enterprise-grade governance by automatically inheriting and enforcing all existing user permissions, ensuring authorized data access for organizations with the strictest requirements, including government, financial services, and healthcare.

"Many organizations still have limited visibility into their AI investments. Organizations need a natural language conversational tool powered by AI to gain better insight into their technology spend and can directly connect costs to measurable business outcomes," said Jevin Jensen, research vice president, IDC. "This replaces guesswork with financial intelligence and allows IT and business leaders to operate from a shared perspective."

End-to-End Visibility: New Capabilities in Cost Modeling and Forecasting

While the Conversational Insights provides the interface, its intelligence is only as powerful as the data it sits on. Simultaneously, Apptio is launching foundational enhancements that feed the AI engine with more comprehensive data from across the hybrid landscape.

Other key updates that feed this Financial Intelligence Layer include:

• IBM Apptio Data Center Total Cost of Ownership (TCO): This new capability helps embed financial governance as organizations scale AI infrastructure readiness, connecting the cost, capacity, and constraints of today's enterprise data center footprint like rack space, cooling, and power. By bridging facility and operational data in a single model, leaders can drill into unit economics, quantify available headroom, and gain the insights needed for a comprehensive cost breakdown by department and identify where there's capacity for further data center investment.

• IBMCloudability Intelligent Forecasting: Integrating IBM's watsonx.ai, this feature uses advanced machine learning models to automatically generate spend forecasts to help improve budgeting accuracy. Its built-in outlier detection is built to remove anomalies, giving FinOps teams a more comprehensive view of future cloud spend to improve budget accuracy.

• Cloudability Advanced Containers: Powered by Kubecost, this add-on solution brings advancedreal-time, container-level cost visibility and savings insights directly into Cloudability. Cloudability Advanced Containers is infrastructure agnostic, allowing you to build real-time visibility into your containerized workloads across any infrastructure type. By integrating granular Kubernetes costs management capabilities directly into Cloudability, DevOps teams can see the cost impact of their work as it happens at the container level, building cost visibility and responsibility directly into the development process.

With AI as the engine, this unified approach transforms technology from a cost center into a strategic business advantage, enabling collaborative, data-driven decisions that optimize investments to maximize business impact.

Conversational Insights is now available in preview and is expected to be generally available in 2026, with Cloudability Intelligent Forecasting and Data Center TCO generally available in Q2 2026. To learn more about Conversational Insights and how Apptio is transforming TBM for the AI era, visit: https://www.apptio.com/innovation-hub/.

[1] Gartner Press Release, Gartner Forecasts Worldwide IT Spending to Grow 10.8% in 2026, Totaling $6.15 Trillion, February 3, 2026

GARTNER is a trademark of Gartner, Inc. and/or its affiliates.

About Apptio, an IBM Company

Apptio, an IBM company, is a leading technology spend and value management software provider. Apptio's AI-powered data insights empower leaders to make smarter financial and operational decisions across Information Technology (IT), multi-cloud FinOps, and digital product development. Apptio's mission is to deliver business value with every technology investment and team. Powered by Apptio's cloud platform, Apptio's SaaS applications help translate technology spend into clear business outcomes and financial ROI. As a pioneer and category leader in Technology Business Management (TBM), FinOps, and Agile Portfolio Management, Apptio works with thousands of customers, partners, and community members worldwide.

Forward-Looking Statements

Statements regarding IBM's future direction and intent are subject to change or withdrawal without notice, and represent goals and objectives only.

Media contact:

Jas McDonald
IBM Communications
Jas.McDonald@ibm.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Apptio Unveils Conversational Insights and New Suite of AI-Powered Capabilities to Translate Complex Technology Spend into Measurable Business Outcomes

Apptio Unveils Conversational Insights and New Suite of AI-Powered Capabilities to Translate Complex Technology Spend into Measurable Business Outcomes

BARCELONA, Spain, June 17, 2026 /PRNewswire/ -- Skin Tech Pharma Group proudly announces that its flagship injectable, RRS® HA LONG LASTING, has been recognized as Best Injectable in the Skin Revitalization category at the AMWC Aesthetic Medicine Awards 2026, one of the most prestigious recognitions in aesthetic medicine.

Since its launch in 2021, RRS® HA LONG LASTING has established itself as a pioneering innovation within the emerging Skin Builder category. With more than 1 million treatments performed worldwide, the product has demonstrated a strong safety and clinical performance profile, helping to redefine aesthetic treatment approaches by combining skin quality improvement with natural-looking restoration.

The award acknowledges the product's contribution to advancing regenerative aesthetic medicine and reflects the growing demand for treatment solutions that deliver natural outcomes while supporting long-term skin health, tissue quality, and graceful ageing.

"Receiving this award is an important milestone for us and a testament to the strength of our long-term strategy. As the aesthetic medicine landscape continues to evolve, our ambition is to lead through scientific rigor, differentiated innovation, and a deep understanding of healthcare professionals' needs. This recognition reinforces our commitment to building sustainable growth while advancing standards of care across the industry."

Márcio Rodrigues, CEO of Skin Tech Pharma Group

About RRS® HA Long Lasting – The Ultimate Skin Builder.

Neither a skin booster nor a dermal filler, RRS® HA Long Lasting combines the most valued characteristics of both categories within a single treatment approach.

RRS® HA Long Lasting is a cross-linked hyaluronic acid skin builder, combined with a protective buffer of 15 amino acids to support dermal structure that enhances hydration, firmness, and texture while giving a subtle lifting effect and improving wrinkles and fine lines. It delivers immediate, natural-looking results, progressive improvements in skin quality, and a proven high safety profile. It is the first skin builder developed with a dual-action approach to address skin ageing in a holistic way, targeting both skin quality and natural facial volume restoration within a single treatment.

Thanks to its advanced technology, the treatment provides progressive improvement in skin quality, promoting a healthier skin appearance. This combined approach allows patients to leave the clinic with an immediate visible effect while experiencing progressive improvement in skin quality in the following weeks, supporting natural-looking results and high patient satisfaction. For more info: LINK

"Clinical use has demonstrated consistent improvements in skin texture, elasticity, and overall luminosity," notes Dr. Javed Hussain, Key Opinion Leader for Skin Tech Pharma Group. "This ultimate Skin Builder is characterised by its hyaluronic acid structure combined with a protective amino acid buffer solution. This provides essential components required for restoration of natural dermal function, which declines with age. In practice, outcomes are reproducible, reliable, and aligned with established safety expectations, while offering a level of durability not typically associated with traditional skin boosters."

About Skin Tech Pharma Group: "30 Years of Innovation"

Skin Tech Pharma Group S.L.U. is a global leader in aesthetic medicine, producing high-quality CE-marked medical devices and advanced cosmeceuticals. Founded in 1994 by Dr. Philippe Deprez and based in Costa Brava, Spain, it is privately owned by Charterhouse Capital Partners and EXCELSIS. The 1996 launch of Easy TCA® established the company as an industry pioneer. Now marking 30 years of innovation, it operates a state-of-the-art in-house laboratory with a global R&D team. The company bridges aesthetic performance with pharmaceutical rigor, delivering trusted, evidence-based solutions worldwide. For more info: LINK

 

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

RRS® HA Long Lasting awarded Best Injectable in Skin Revitalization at AMWC 2026, reinforcing Skin Tech Pharma Group's leadership in the Skin Builder category

RRS® HA Long Lasting awarded Best Injectable in Skin Revitalization at AMWC 2026, reinforcing Skin Tech Pharma Group's leadership in the Skin Builder category